Publications
Representative of >140 publications:
· Chang Y, Cesarman E, Pessin M, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of new human herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266:1865-1869, 1994.
· Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas. New Engl J Med, 332:1186-1191, 1995.
· Arvanitakis L, Geras-Raaka E, Gershengorn MC, Cesarman E. KS herpesvirus encodes a constitutively active G protein-coupled receptor linked to cell proliferation. Nature 385:347-350, 1997.
· Flore O, Rafii S, Ely J, O'Leary JO, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394, 588-592, 1998.
· Cesarman E. Kaposi's sarcoma-associated herpesvirus--the high cost of viral survival. N Engl J Med, 349:1107-1109,2003.
· Guasparri I, Keller SA, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003, 2004.
· Guasparri I, Wu H, Cesarman E. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep, 7:114-119.
· Guasparri I, Bubman D, Cesarman E. EBV LMP2A mediated LMP1 signaling and survival of lymphoma cells through TRAF2 regulation. Blood, 111:3813-3820, 2008.
· Di Bartolo D, Cannon M, Liu YF, Renne R, Chadburn A, Boshoff C, Cesarman E. Kaposi's sarcoma herpesvirus LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood, 111:4731-4740, 2008.
· Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E, and the AIDS Malignancy Consortium. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium Clinical Trials 010 and 034. J Clin Oncology, 27:5039-48, 2009.
· de Oliveira DE, Ballon G, Cesarman E. NF-kappaB signaling modulation by EBV and KSHV.& & Trends Microbiol. 18:248-57, 2010.
· Mesri MA, Cesarman E and Boshoff C.& Kaposi's sarcoma and its associated herpesvirus. Nature Reviews Cancer 10:707-19, 2010.
· Krown SE, Dittmer DP, Cesarman E.& & Pilot Study of Oral Valganciclovir in Patients with Classic Kaposi Sarcoma. J. Infectious Diseases, 203:1082-6, 2011.
· Gianna Ballon, Kang Chen, Rocio Perez,Wayne Tam, and Ethel Cesarman. Kaposi Sarcoma Herpesvirus (KSHV) vFLIP Induces B-cell Transdifferentiation and Tumorigenesis in Mice. J Clin Invest, 121:1141-1152, 2011.
- Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E. A20 (TNFAIP3) Genetic Alterations in EBV Associated AIDS Related Lymphoma. Blood,20:1114-1120, 2011.
- Mesri EA, Cesarman E. Kaposi's sarcoma herpesvirus oncogenesis is a Notch better in 3D. Cell Host Microbe10:529-31, 2011.
